Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 42, 2012, Pages 17016-17021

  Tesla, Rachel ^a   Wolf, HamiltonParker ^a   Xu, Pin ^b   Drawbridge, Jordan ^b   Estill, SandiJo ^a   Huntington, Paula ^b   McDaniel, LaTisha ^a   Knobbe, Whitney ^b   Burket, Aaron ^b   Tran, Stephanie ^b   Starwalt, Ruth ^a   Morlock, Lorraine ^a   Naidoo, Jacinth ^a   Williams, Noelle S ^a   Ready, Joseph M ^a   McKnight, Steven L ^a   Pieper, Andrew A ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CARBAZOLE DERIVATIVE; COPPER ZINC SUPEROXIDE DISMUTASE; DIMEBON; P7C3; P7C3A20; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CORRELATION COEFFICIENT; DENTATE GYRUS; DISEASE COURSE; DRUG EFFICACY; FEMALE; GAIT; HIPPOCAMPUS; MOTONEURON; MOTOR PERFORMANCE; MOUSE; MOUSE STRAIN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; ROTAROD TEST; SPINAL CORD VENTRAL HORN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CARBAZOLES; INDOLES; MICE; MOTOR ACTIVITY; MOTOR NEURONS; NEUROPROTECTIVE AGENTS; POLYMERASE CHAIN REACTION; ROTAROD PERFORMANCE TEST; SPINAL CORD;

EID: 84867639321     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1213960109     Document Type: Article

References (28)

1. Tandan R, Bradley WG (1985) Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol 18:271-280. (Pubitemid 15023099)
2. Valdmanis PN, Daoud H, Dion PA, Rouleau GA (2009) Recent advances in the genetics of amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep 9:198-205.
3. Rosen DR, et al. (1993) Mutations in Cu/ZN superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364:59-62. (Pubitemid 23087289)
4. Shaw CE, et al. (1997) Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD1 mutation. Neurology 49:1612-1616. (Pubitemid 28015126)
5. Valentine JS, Doucette PA, Zittin Potter S (2005) Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74:563-593. (Pubitemid 40995518)
6. Bruijn LI, et al. (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281:1851-1854. (Pubitemid 28450505)
7. Furukawa Y, Fu R, Deng HX, Siddique T, O'Halloran TV (2006) Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice. Proc Natl Acad Sci USA 103:7148-7153.
8. Prudencio M, Hart PJ, Borchelt DR, Andersen PM (2009) Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease. Hum Mol Genet 18:3217-3226.
9. Wang Q, Johnson JL, Agar NY, Agar JN (2008) Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol 6:e170.
10. Boillée S, Vande Velde C, Cleveland DW (2006) ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59. (Pubitemid 44466358)
11. Valentine JS, Hart PJ (2003) Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 100:3617-3622. (Pubitemid 36418082)
12. Gurney ME, et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772-1775. (Pubitemid 24227760)
13. Pieper AA, et al. (2010) Discovery of a proneurogenic, neuroprotective chemical. Cell 142:39-51.
14. Pieper AA, et al. (2005) The neuronal PAS domain protein 3 transcription factor controls FGF-mediated adult hippocampal neurogenesis in mice. Proc Natl Acad Sci USA 102:14052-14057. (Pubitemid 41377701)
15. MacMillan KS, et al. (2011) Development of proneurogenic, neuroprotective small molecules. J Am Chem Soc 133:1428-1437.
16. McKnight SL, Pieper AA, Ready JM, De Brabander J (2010) Proneurogenic Compounds. US Patent 2010/020681.
17. Bachurin S, et al. (2001) Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer. Ann N Y Acad Sci 939:425-435. (Pubitemid 32620096)
18. Bachurin SO, Shevtsova EP, Kireeva EG, Oxenkrug GF, Sablin SO (2003) Mitochondria as a target for neurotoxins and neuroprotective agents. Ann N Y Acad Sci 993:334-344, discussion 345- 349.
19. De Jesús-Cortés H, et al. (2012) Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease. Proc Natl Acad Sci USA 109:17010-17015.
20. Letiner M, Menzies S, Lutz C (2010) Working with ALS mice. Guidelines for Preclinical Testing & Colony Management (The Jackson Laboratory, Bar Harbor, ME).
21. Ludolph AC, et al.; ENMC Group for the Establishment of Guidelines for the Conduct of Preclinical and Proof of Concept Studies in ALS/MND Models (2007) Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: Report on the 142nd ENMC international workshop. Amyotroph Lateral Scler 8:217-223. (Pubitemid 47190225)
22. Da Cruz S, et al. (2012) Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab 15:567-569.
23. Kariya S, et al. (2012) Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies. Hum Mol Genet 21:3421-3434.
24. Rouaux C, et al. (2007) Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J Neurosci 27:5535-5545. (Pubitemid 350021087)
25. Carter RJ, Morton J, Dunnet SB (2001) Motor coordination and balance in rodents. Curr Protoc Neurosci 8.12. Available at www.currentprotocols.com.
26. Jackson M, Ganel R, Rothstein JD (2002) Models of amyotrophic lateral sclerosis. Curr Protoc Neurosci 9.13. Available at www.currentprotocols.com.
27. Doody RS, et al.; dimebon investigators (2008) Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-tomoderate Alzheimer's disease: A randomised, double-blind, placebo-controlled study. Lancet 372:207-215. (Pubitemid 351978110)
28. Steele JW, et al. (2012) Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model. Mol Psych, 10.1038/mp.2012.106.